ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

LNTH Lantheus Holdings Inc

81.83
1.31 (1.63%)
May 31 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 824,280
Bid Price 81.01
Ask Price 83.14
News (2)
Day High 82.083

Low
50.20

52 Week Range

High
94.47

Day Low 80.69
Share Name Share Symbol Market Stock Type
Lantheus Holdings Inc LNTH NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
1.31 1.63% 81.83 19:00:00
Open Price Low Price High Price Close Price Previous Close
80.82 80.69 82.083 81.83 80.52
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
13,639 824,280 US$ 81.64 US$ 67,291,038 - 50.20 - 94.47
Last Trade Type Quantity Price Currency
18:49:58 2 US$ 82.50 USD

Lantheus Holdings Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
5.61B 68.53M - 1.3B 326.66M 4.77 17.17
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Lantheus News

Date Time Source News Article
5/31/202415:30Edgar (US Regulatory)Form SD - Specialized disclosure report
5/31/202410:30Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
5/30/202415:34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
5/30/202409:27Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
5/28/202410:59Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
5/28/202407:00GlobeNewswire Inc.Lantheus to Present at the William Blair 44th Annual Growth..
5/22/202420:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
5/21/202415:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
5/15/202416:09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
5/15/202415:43Edgar (US Regulatory)Form 8-K - Current report
5/15/202415:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
5/15/202415:30GlobeNewswire Inc.Lantheus Announces Executive Appointments to Accelerate..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No LNTH Message Board. Create One! See More Posts on LNTH Message Board See More Message Board Posts

Historical LNTH Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week79.9982.08377.1079.41688,9831.842.30%
1 Month78.0082.9274.2878.12852,0583.834.91%
3 Months63.0382.9256.4467.97876,07818.8029.83%
6 Months70.8482.9250.2063.071,149,82610.9915.51%
1 Year87.0894.4750.2068.211,070,180-5.25-6.03%
3 Years24.36100.4822.2062.66981,25857.47235.92%
5 Years24.62100.488.6750.95787,45557.21232.37%

Lantheus Description

Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its imaging products and agents assist clinicians in the diagnosis and treatment of cardiovascular and other diseases. Its agents are typically non-radioactive compounds that are used in diagnostic procedures, such as cardiac ultrasounds, or echocardiograms, x-ray imaging used by physicians to progress the clarity of the diagnostic image. Its portfolio of imaging products includes medical radiopharmaceuticals such as DEFINITY, TechneLite, Xenon Xe 133 Gas, Cardiolite, and Neurolite. Its revenue is generated from the sales of diagnostic imaging agents to wholesalers, distributors radiopharmacy and directly to hospitals and clinics predominantly in the United States.

Your Recent History

Delayed Upgrade Clock